Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8+ T cells during the primary immune response is a research paper published in Immunity (2021). On theSindex it has a DataRank of 0.729. It has been cited 128 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.729
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P30DK063720
National Institutes of Health
Grant: S10OD021822
National Institutes of Health
Grant: S10OD018040
National Institutes of Health
Grant: IL-2
National Cancer Institute
Grant: F30CA239367
National Cancer Institute
Grant: R01DK105550
National Cancer Institute
Grant: DP5OD023056
National Cancer Institute
Grant: R01HL136664
Conquer Cancer Foundation
Grant: CA-0122026
NIGMS NIH HHS
Grant: T32 GM152284
NIGMS NIH HHS
Grant: T32 GM007347
National Institutes of Health
Grant: 5DP5OD023056-04
Quantitatively modeling immune responses to cancer
National Institutes of Health
Grant: 1S10OD021822-01
BD FACSAria Fusion Cell Sorter
National Institutes of Health
Grant: 5R01HL136664-06
Targeting T cell glutamine metabolism in severe asthma
National Institutes of Health
Grant: 5P30DK063720-03
ISLET PRODUCTION FACILITY CORE
National Institutes of Health
Grant: 5F30CA239367-02
Glycolysis and Glutaminase in CD8 T cell differentiation and anti-tumor immunity
National Institutes of Health
Grant: 1S10OD018040-01
UCSF DVS CyTOF Mass Cytometer
National Institutes of Health
Grant: 2R01DK105550-07
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory disease
Merck
Bayer Fund
Spectrum Pharmaceuticals
Chan Zuckerberg Initiative
Pfizer
University of California, San Francisco
American Society of Clinical Oncology
Parker Institute for Cancer Immunotherapy
Bristol-Myers Squibb
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals